A shortage of blood for transfusions for injured animals has resulted in the introduction of a synthesized product called Oxyglobin, which can be used effectively as a blood replacement. The manufacturer of the product has put a high price on the product in order to recoup its research and development costs. The manufacturer of Oxyglobin is using a ___ policy.
a. price banding
b. penetration pricing
c. price lining
d. bundling costs
e. price skimming
ANSWER: e